Don't worry as over the next few years there should be readouts from the five (pancreatic, ovarian, NSCLC, NSCLC brain mets and rGBM) pivotal trials. Also, they plan to start another (pivotal) in HCC, and there should be data from the KEYNOTE trials as well.
10 years when this trial is still post data lock with no publication, no BLA submission and no revenue generation. But NWBO will still be paying Advent. Or the next CDMO LP builds and sells on the backs (and money) of NWBO shareholders.
Not every biotech is on NWBOs schedule of accomplishing nothing and never finishing a trial in what is it, 11 years now?
Market Data 
Markets 
AI
